Diagnosed with a hematologic disease or malignancy

Scheduled to receive nonablative conditioning with fludarabine and total body irradiation

Donor is well-matched by high resolution DNA techniques.

Scheduled to receive postgrafting immunosuppression of oral MMF (CellCept) and an oral calcineurin inhibitor.

Age \>18 years at the time of enrollment.

Blood Samples to Evaluate Biomarkers of Donor Chimerism